a comparison of clinical outcomes from zuma-5 and the international scholar-5 external control c...
Published 3 years ago • 58 plays • Length 3:40Download video MP4
Download video MP3
Similar videos
-
1:44
comparison of zuma-1 and scholar-1 outcomes
-
4:51
zuma-5: axi-cel for r/r non-hodgkin lymphoma
-
2:43
long-term follow-up results of zuma-5: axi-cel in patients with r/r indolent nhl
-
4:59
zuma-7: axi-cel is superior to standard of care across common prognostic subgroups in r/r lbcl
-
1:51
measuring value in new health technology assessments: a focus on robotic surgery in public hospitals
-
2:38
zuma-1 & scholar-1: comparison of outcomes in refractory dlbcl
-
2:26
zuma-5: high orr and cr for r/r inhl with axi-cel
-
9:36
dr. mahmoud elsawy on interim analysis of zuma-5: a phase ii study of axicabtagene...
-
26:31
survival analysis overview
-
1:45:44
vascular findings normal variants or more?
-
4:41
answers from the experts: cutaneous b-cell lymphoma variants
-
4:26
axicabtagene ciloleucel vs standard‑of‑care therapy for relapsed/refractory large b-cell lymphoma
-
1:15
primary overall survival analysis of the zuma-7 trial
-
1:20
interaction qualified primary hepatocytes | lonza product overview
-
1:46
donorplex™ pooled donor human hepatocytes enable the next level of reliability | lonza
-
2:01
hepatocyte-like cells from human embryonic stem cell populations l protocol preview
-
7:35
axicabtagene ciloleucel provides superior efs vs standard of care in elderly with relapsed/refra...
-
3:46
zuma-5 update: retreatment of r/r inhl with axi-cel
-
3:17
lori leslie, md, discusses outcomes from the phase ii zuma-5 study presented at ash 2020
-
3:27
julio chavez, md, ms, shares outcomes from the zuma-5 study presented at ash 2020
-
3:18
zuma-5: axi-cel for r/r inhl